Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-20

Clinical Trial Update: Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating autologous transplantation of melanocytes for vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royan Institute | Conditions: Vitiligo | Phase 3 | Status: COMPLETED